Compare OVID & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | ASPN |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 365.5M | 321.4M |
| IPO Year | 2017 | 2011 |
| Metric | OVID | ASPN |
|---|---|---|
| Price | $2.76 | $5.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $4.60 | $4.25 |
| AVG Volume (30 Days) | ★ 2.5M | 1.7M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,252,000.00 | ★ $271,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.34 | $50.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.27 | $2.30 |
| 52 Week High | $3.11 | $9.78 |
| Indicator | OVID | ASPN |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 74.43 |
| Support Level | $2.56 | $3.01 |
| Resistance Level | $3.11 | $8.51 |
| Average True Range (ATR) | 0.15 | 0.31 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 44.83 | 82.05 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.